Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D
Eur Urol Oncol. 2024 Jun 25:S2588-9311(24)00145-7. doi: 10.1016/j.euo.2024.05.013.…
Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma
Nat Commun. 2024 Jun 24;15(1):5352. doi: 10.1038/s41467-024-49718-8.ABSTRACTImmune…
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma
J Immunother Cancer. 2024 Jun 6;12(6):e009028. doi: 10.1136/jitc-2024-009028.ABSTRACTBACKGROUND:…
A phase II study (AARDVARC) of AZD4635 in combination with durvalumab and cabazitaxel in patients with progressive, metastatic, castration-resistant prostate cancer
ESMO Open. 2024 Jun 4;9(6):103446. doi: 10.1016/j.esmoop.2024.103446.…
Merkel-cell carcinoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO Open. 2024 May;9(5):102977. doi: 10.1016/j.esmoop.2024.102977.…
A Signal-finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration-Resistant Prostate Cancer: Results from CYCLONE 1
Clin Cancer Res. 2024 Mar 21. doi: 10.1158/1078-0432.CCR-23-3436.…
Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial
Eur Urol. 2024 Mar 14:S0302-2838(24)02133-X. doi: 10.1016/j.eururo.2024.02.016.…
1,4-dihydroxy quininib activates ferroptosis pathways in metastatic uveal melanoma and reveals a novel prognostic biomarker signature
Cell Death Discov. 2024 Feb 10;10(1):70. doi: 10.1038/s41420-023-01773-8.ABSTRACTUveal…
Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors
Cancer Immunol Immunother. 2024 Jan 5;73(1):5. doi: 10.1007/s00262-023-03611-3.ABSTRACTCancer…
Driver mutations in GNAQ and GNA11 genes as potential targets for precision immunotherapy in uveal melanoma patients
Oncoimmunology. 2023 Oct 24;12(1):2261278. doi: 10.1080/2162402X.2023.2261278.…
Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model
Front Oncol. 2023 Nov 20;13:1259314. doi: 10.3389/fonc.2023.1259314.…
Overall Survival From Tebentafusp Versus Nivolumab Plus Ipilimumab in First Line Metastatic Uveal Melanoma: A Propensity Score Weighted Analysis
Ann Oncol. 2023 Dec 2:S0923-7534(23)05100-1. doi: 10.1016/j.annonc.2023.11.013.…
